We are live on ! Find out more
Aster Capital Management

Aster Capital Management Portfolio holdings

AUM $275M Turnover 72.56%
1-Year Est. Return 18.46%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+18.46%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$275M
AUM Growth
-$195M
Cap. Flow
-$180M
Cap. Flow %
-65.37%
Top 10 Hldgs %
10.94%
Holding
1,392
New
584
Increased
169
Reduced
213
Closed
426
Avg Time Held
0.2 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.57M
2
OVV icon
Ovintiv
OVV
+$3.99M
3
KIM icon
Kimco Realty
KIM
+$3.52M
4
ALAB icon
Astera Labs
ALAB
+$3.33M
5
HUT icon
Hut 8
HUT
+$2.16M

Top Sells

Rank Stock Value
1
IYR icon
iShares US Real Estate ETF
IYR
+$11.3M
2
AAPL icon
Apple
AAPL
+$7.75M
3
MSFT icon
Microsoft
MSFT
+$6.82M
4
HON icon
Honeywell
HON
+$6.34M
5
KO icon
Coca-Cola
KO
+$5.38M

Sector Composition

Rank Sector Weight
1 Financials 16.08%
2 Technology 15.72%
3 Industrials 13.9%
4 Healthcare 13.43%
5 Consumer Discretionary 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DXCM icon
476
DexCom
DXCM
$29.6B
$90.7K 0.03%
1,051
+964
+1,108% +$80.2K
2025 Q4
3 quarters
ETOR icon
477
eToro Group
ETOR
$1.48B
$90.2K 0.03%
+3,511
New +$116K
2026 Q3
0 quarters
BLSM
478
BlossomHill Therapeutics
BLSM
$461M
$89.9K 0.03%
+4,822
New +$95.8K
2026 Q3
0 quarters
CYTK icon
479
Cytokinetics
CYTK
$7.07B
$89.4K 0.03%
+1,356
New +$103K
2026 Q3
0 quarters
HUM icon
480
Humana
HUM
$46.8B
$89.3K 0.03%
+234
New +$91K
2026 Q3
0 quarters
U icon
481
Unity
U
$19.9B
$88.4K 0.03%
+2,159
New +$83K
2026 Q3
0 quarters
DVA icon
482
DaVita
DVA
$10.1B
$88K 0.03%
503
-1,317
-72% -$264K
2025 Q4
3 quarters
BBOT icon
483
BridgeBio Oncology
BBOT
$145M
$87K 0.03%
+21,220
New +$165K
2026 Q3
0 quarters
ADP icon
484
Automatic Data Processing
ADP
$119B
$87K 0.03%
+337
New +$89.4K
2026 Q3
0 quarters
KDK icon
485
Kodiak AI
KDK
$174M
$86.7K 0.03%
+45,159
New +$181K
2026 Q3
0 quarters
ETRA
486
Electra Therapeutics
ETRA
$510M
$86K 0.03%
+7,643
New +$94.1K
2026 Q3
0 quarters
EPRT icon
487
Essential Properties Realty Trust
EPRT
$6.17B
$86K 0.03%
3,331
+2,068
+164% +$62.4K
2026 Q2
1 quarter
NVA
488
Nova Minerals
NVA
$76.4M
$85.9K 0.03%
+15,852
New +$83.4K
2026 Q3
0 quarters
TW icon
489
Tradeweb Markets
TW
$26.4B
$85.7K 0.03%
+850
New +$87.3K
2026 Q3
0 quarters
DOCU icon
490
DocuSign
DOCU
$13.9B
$85.7K 0.03%
+1,276
New +$75.9K
2026 Q3
0 quarters
DUOL icon
491
Duolingo
DUOL
$6.84B
$84.9K 0.03%
596
-1,840
-76% -$255K
2026 Q2
1 quarter
BNC icon
492
BNB Standard
BNC
$149M
$84.4K 0.03%
+14,334
New +$50.5K
2026 Q3
0 quarters
BRX icon
493
Brixmor Property Group
BRX
$9.3B
$84.4K 0.03%
3,058
-9,618
-76% -$289K
2026 Q1
2 quarters
DHX icon
494
DHI Group
DHX
$159M
$84.2K 0.03%
+17,908
New +$76.1K
2026 Q3
0 quarters
LYNX
495
Lyntris
LYNX
$1.4B
$83.5K 0.03%
+6,769
New +$91.3K
2026 Q3
0 quarters
WTW icon
496
Willis Towers Watson
WTW
$30.5B
$83.3K 0.03%
+289
New +$91.3K
2026 Q3
0 quarters
AIAI icon
497
AIAI Holdings
AIAI
$59.5M
$82.9K 0.03%
+25,820
New +$147K
2026 Q3
0 quarters
BLZE icon
498
Backblaze
BLZE
$407M
$81.6K 0.03%
+5,833
New +$87.6K
2026 Q3
0 quarters
QTTB icon
499
Q32 Bio
QTTB
$250M
$81.2K 0.03%
+9,817
New +$136K
2026 Q3
0 quarters
GWW icon
500
W.W. Grainger
GWW
$63.5B
$81K 0.03%
+65
New +$85.8K
2026 Q3
0 quarters

Similar funds

Aster Capital Management's Q3 2026 Portfolio in Review

As of Q3 2026, Aster Capital Management held 1,392 positions worth $275M, down 41% from $470M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Aster Capital Management withdrew a net $180M in Q3 2026, closing 426 positions and reducing 213 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $11.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Aster Capital Management opened a new position in Alnylam Pharmaceuticals worth $4.43M.

  • Aster Capital Management's largest Q3 2026 buy was Alnylam Pharmaceuticals: 17,949 shares worth $4.43M.
  • Aster Capital Management added most to Simon Property Group in Q3 2026, an estimated $1.93M increase.
  • Aster Capital Management's biggest Q3 2026 reduction was Meta Platforms (Facebook), cutting an estimated $4.29M.
  • Aster Capital Management fully exited iShares US Real Estate ETF in Q3 2026, selling an estimated $11.3M.
  • Aster Capital Management's ten largest holdings make up 11% of its $275M portfolio in Q3 2026.
  • Aster Capital Management opened 584 new positions and closed 426 in Q3 2026.
  • Aster Capital Management's portfolio value fell 41% quarter-over-quarter to $275M.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.